美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Lexaria Bioscience Corp

0.1492

0.0000

成交量：47.00

成交額：5.10

市值：76.16萬

市盈率：- -

高：0.1492

開：0.1492

低：0.1492

收：0.1492

資料載入中...

總覽公司新聞公告

Lexaria Bioscience Corp.盤中異動股價大漲5.17%報1.22美元

Lexaria Bioscience Corp.股價重挫14.50% 市值跌367.91萬美元

Lexaria Bioscience Corp.盤中異動臨近收盤股價大漲5.03%報1.67美元

Lexaria Bioscience Corp.盤中異動早盤快速上漲5.70%報1.47美元

Lexaria Bioscience Corp.盤中異動早盤快速拉昇5.00%

Lexaria Bioscience Corp.盤中異動早盤快速上漲9.63%

Lexaria Bioscience Corp.盤中異動股價大跌5.00%報1.33美元

Lexaria Bioscience Corp.盤中異動早盤快速拉昇7.17%

Lexaria Bioscience Corp.盤中異動股價大跌5.19%

Lexaria Bioscience Corp.盤中異動早盤大幅下挫5.38%

Lexaria Bioscience Corp.盤中異動下午盤股價大漲5.22%

Lexaria Bioscience Corp.盤中異動股價大跌5.52%報1.37美元

Lexaria Bioscience Corp.盤中異動臨近午盤快速拉昇5.74%報1.28美元

Lexaria Bioscience Corp.盤中異動下午盤股價大跌6.80%報1.37美元

Lexaria Bioscience Corp.盤中異動大幅下挫5.80%報1.46美元

Lexaria Bioscience Corp.盤中異動早盤股價大跌5.20%

Lexaria Bioscience Corp.盤中異動快速上漲5.51%報1.53美元

Lexaria Bioscience Corp.盤中異動快速拉昇5.29%

Lexaria Bioscience Corp.盤中異動快速下挫5.00%報1.52美元

Lexaria Bioscience Corp.盤中異動股價大漲5.23%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/LEXXW/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LEXXW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LEXXW\",,,,,undefined,":{"symbol":"LEXXW","market":"US","secType":"STK","nameCN":"Lexaria Bioscience Corp","latestPrice":0.1492,"timestamp":1753452542956,"preClose":0.1492,"halted":0,"volume":47,"delay":0,"floatShares":5104300,"shares":5104300,"eps":0,"marketStatus":"交易中","change":0,"latestTime":"07-25 14:33:58 EDT","open":0.1492,"high":0.1492,"low":0.1492,"amount":5.1042000000000005,"amplitude":0,"askPrice":0.1651,"askSize":100,"bidPrice":0.1293,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1753473600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.1492,"volumeRatio":0.407406},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LEXXW\",,,,,undefined,":{"symbol":"LEXXW","floatShares":5104300,"roa":"-84.74%","roe":"-152.89%","lyrEps":0,"volumeRatio":0.407406,"shares":5104300,"dividePrice":0,"high":0.1492,"amplitude":0,"preClose":0.1492,"low":0.1492,"week52Low":0.0685,"pbRate":"0.14","psRate":"1.24","week52High":2,"institutionHeld":0,"latestPrice":0.1492,"eps":0,"divideRate":0,"volume":47,"delay":0,"ttmEps":0,"open":0.1492,"prevYearClose":0.7641,"prevWeekClose":0.15,"prevMonthClose":0.1,"prevQuarterClose":0.1,"fiveDayClose":0.15,"twentyDayClose":0.15,"sixtyDayClose":0.3017},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LEXXW\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532887279","title":"Lexaria Bioscience Corp.盤中異動 股價大漲5.17%報1.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532887279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532887279?lang=zh_tw&edition=fundamental","pubTime":"2025-05-02 03:53","pubTimestamp":1746129196,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日03时53分，Lexaria Bioscience Corp.股票出现异动，股价快速拉升5.17%。截至发稿，该股报1.22美元/股，成交量12.038万股，换手率0.69%，振幅3.88%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体跌幅为0.58%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050203531694ea2583&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050203531694ea2583&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LEXX","LEXXW"],"gpt_icon":0},{"id":"2530313411","title":"Lexaria Bioscience Corp.股價重挫14.50% 市值跌367.91萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530313411","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530313411?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 21:32","pubTimestamp":1745587929,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日21时32分，Lexaria Bioscience Corp.股票出现异动，股价大幅跳水14.50%。截至发稿，该股报1.45美元/股，成交量10.614万股，换手率0.60%，振幅3.55%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体跌幅为0.47%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213209a6c81d39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213209a6c81d39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXX","BK4007","LEXXW"],"gpt_icon":0},{"id":"2530596033","title":"Lexaria Bioscience Corp.盤中異動 臨近收盤股價大漲5.03%報1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530596033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530596033?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 03:50","pubTimestamp":1745524232,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日03时50分，Lexaria Bioscience Corp.股票出现异动，股价快速上涨5.03%。截至发稿，该股报1.67美元/股，成交量5.7283万股，换手率0.33%，振幅8.81%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体涨幅为0.58%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425035032a465ca69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425035032a465ca69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXX","BK4007","LEXXW"],"gpt_icon":0},{"id":"2529058437","title":"Lexaria Bioscience Corp.盤中異動 早盤快速上漲5.70%報1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529058437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529058437?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 21:47","pubTimestamp":1745329675,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时47分，Lexaria Bioscience Corp.股票出现异动，股价急速拉升5.70%。截至发稿，该股报1.47美元/股，成交量2367股，换手率0.01%，振幅2.16%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体涨幅为1.30%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422214755a4628dce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422214755a4628dce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LEXXW","LEXX"],"gpt_icon":0},{"id":"2528743745","title":"Lexaria Bioscience Corp.盤中異動 早盤快速拉昇5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528743745","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528743745?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 21:35","pubTimestamp":1744896907,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日21时35分，Lexaria Bioscience Corp.股票出现异动，股价快速上涨5.00%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体涨幅为0.48%。其相关个股中，Channel Therapeutics Corporation、Uniqure N.V.、硕迪生物涨幅较大，Channel Therapeutics Corporation、Clearmind Medicine Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为375.91%、136.30%、44.67%，振幅较大的相关个股有Channel Therapeutics Corporation、Sol-Gel Technologies Ltd.、Palatin Technologies, Inc.，振幅分别为27.09%、15.63%、12.97%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417213508aa2c72db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417213508aa2c72db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LEXX","LEXXW"],"gpt_icon":0},{"id":"2527164264","title":"Lexaria Bioscience Corp.盤中異動 早盤快速上漲9.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527164264","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527164264?lang=zh_tw&edition=fundamental","pubTime":"2025-04-14 21:37","pubTimestamp":1744637822,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日21时37分，Lexaria Bioscience Corp.股票出现波动，股价急速上涨9.63%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体涨幅为0.83%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Theratechnologies Inc.、Third Harmonic Bio, Inc.涨幅较大，Aditxt, Inc.、Processa Pharmaceuticals, Inc.、Soligenix, Inc.较为活跃，换手率分别为280.08%、136.26%、87.17%，振幅较大的相关个股有Artelo Biosciences, Inc.、Verrica制药、Verve Therapeutics, Inc.，振幅分别为18.25%、17.60%、16.87%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414213702a6ba1db4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414213702a6ba1db4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXX","BK4007","LEXXW"],"gpt_icon":0},{"id":"2526560973","title":"Lexaria Bioscience Corp.盤中異動 股價大跌5.00%報1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526560973","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526560973?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 21:33","pubTimestamp":1744292018,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日21时33分，Lexaria Bioscience Corp.股票出现波动，股价快速跳水5.00%。截至发稿，该股报1.33美元/股，成交量1.154万股，换手率0.07%，振幅5.00%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体跌幅为0.85%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410213338a45501a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410213338a45501a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LEXXW","LEXX"],"gpt_icon":0},{"id":"2526636244","title":"Lexaria Bioscience Corp.盤中異動 早盤快速拉昇7.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526636244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526636244?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 21:37","pubTimestamp":1744205840,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日21时37分，Lexaria Bioscience Corp.股票出现异动，股价大幅上涨7.17%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体跌幅为1.62%。其相关个股中，Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Lixte Biotechnology Holdings, Inc.、Osr Holdings, Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Aditxt, Inc.、Revelation Biosciences, Inc.较为活跃，换手率分别为1664.38%、189.97%、157.69%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Nextcure, Inc.、Lixte Biotechnology Holdings, Inc.，振幅分别为107.34%、21.84%、18.59%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040921372097334e6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040921372097334e6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LEXXW","LEXX"],"gpt_icon":0},{"id":"2524784989","title":"Lexaria Bioscience Corp.盤中異動 股價大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524784989","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524784989?lang=zh_tw&edition=fundamental","pubTime":"2025-04-04 22:29","pubTimestamp":1743776985,"startTime":"0","endTime":"0","summary":"北京时间2025年04月04日22时29分，Lexaria Bioscience Corp.股票出现异动，股价大幅跳水5.19%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体跌幅为1.33%。其相关个股中，Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Impact Biomedical, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Impact Biomedical, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为2068.04%、636.21%、325.11%，振幅较大的相关个股有Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Impact Biomedical, Inc.、Virpax Pharmaceuticals Inc，振幅分别为455.04%、63.13%、60.00%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404222946972e8339&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404222946972e8339&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXXW","BK4007","LEXX"],"gpt_icon":0},{"id":"2524613962","title":"Lexaria Bioscience Corp.盤中異動 早盤大幅下挫5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524613962","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524613962?lang=zh_tw&edition=fundamental","pubTime":"2025-04-03 22:02","pubTimestamp":1743688951,"startTime":"0","endTime":"0","summary":"北京时间2025年04月03日22时02分，Lexaria Bioscience Corp.股票出现异动，股价大幅下跌5.38%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Protagenic Therapeutics, Inc.、Aptevo Therapeutics Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Aptevo Therapeutics Inc.、Protagenic Therapeutics, Inc.、Genprex, Inc.较为活跃，换手率分别为3241.45%、1552.90%、350.80%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Protagenic Therapeutics, Inc.、Context Therapeutics Inc.，振幅分别为84.06%、73.57%、38.77%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040322023294cb3272&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040322023294cb3272&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXX","BK4007","LEXXW"],"gpt_icon":0},{"id":"2518776160","title":"Lexaria Bioscience Corp.盤中異動 下午盤股價大漲5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518776160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518776160?lang=zh_tw&edition=fundamental","pubTime":"2025-03-12 03:26","pubTimestamp":1741721163,"startTime":"0","endTime":"0","summary":"北京时间2025年03月12日03时26分，Lexaria Bioscience Corp.股票出现波动，股价急速拉升5.22%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体跌幅为1.47%。其相关个股中，Dermata Therapeutics Inc C/Wts 、2Seventy Bio, Inc.、Syros Pharmaceuticals, Inc.涨幅较大，Syros Pharmaceuticals, Inc.、Dogwood Therapeutics, Inc.、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为2524.45%、935.12%、424.23%，振幅较大的相关个股有Syros Pharmaceuticals, Inc.、Surrozen Inc C/Wts 01/08/2031 、Dermata Therapeutics Inc C/Wts ，振幅分别为171.29%、144.00%、92.16%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250312032604ab5e7f6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250312032604ab5e7f6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXX","LEXXW","BK4007"],"gpt_icon":0},{"id":"2518648272","title":"Lexaria Bioscience Corp.盤中異動 股價大跌5.52%報1.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518648272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518648272?lang=zh_tw&edition=fundamental","pubTime":"2025-03-10 23:46","pubTimestamp":1741621563,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时46分，Lexaria Bioscience Corp.股票出现异动，股价急速跳水5.52%。截至发稿，该股报1.37美元/股，成交量8016股，换手率0.05%，振幅4.60%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体涨幅为0.14%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310234603a26a56f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310234603a26a56f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXX","LEXXW","BK4007"],"gpt_icon":0},{"id":"2517944023","title":"Lexaria Bioscience Corp.盤中異動 臨近午盤快速拉昇5.74%報1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517944023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517944023?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 00:48","pubTimestamp":1741193323,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时48分，Lexaria Bioscience Corp.股票出现异动，股价急速上涨5.74%。截至发稿，该股报1.28美元/股，成交量1.2288万股，换手率0.07%，振幅6.57%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体涨幅为0.96%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306004843963afbb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306004843963afbb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXXW","LEXX","BK4007"],"gpt_icon":0},{"id":"2516654650","title":"Lexaria Bioscience Corp.盤中異動 下午盤股價大跌6.80%報1.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516654650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516654650?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 03:30","pubTimestamp":1741030218,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时30分，Lexaria Bioscience Corp.股票出现波动，股价急速下挫6.80%。截至发稿，该股报1.37美元/股，成交量6.1314万股，换手率0.35%，振幅8.16%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体涨幅为0.58%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040330189637eebf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040330189637eebf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LEXXW","LEXX"],"gpt_icon":0},{"id":"2516370323","title":"Lexaria Bioscience Corp.盤中異動 大幅下挫5.80%報1.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516370323","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516370323?lang=zh_tw&edition=fundamental","pubTime":"2025-03-01 02:13","pubTimestamp":1740766392,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日02时13分，Lexaria Bioscience Corp.股票出现异动，股价快速下挫5.80%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Enveric Biosciences, Inc.、Camp4 Therapeutics Corporation、Bioxcel Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3169.21%、525.79%、377.11%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为57.80%、49.90%、48.19%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301021312a25836ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301021312a25836ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXX","BK4007","LEXXW"],"gpt_icon":0},{"id":"2514165490","title":"Lexaria Bioscience Corp.盤中異動 早盤股價大跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514165490","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514165490?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 23:36","pubTimestamp":1740497787,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时36分，Lexaria Bioscience Corp.股票出现波动，股价大幅下跌5.20%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体涨幅为0.86%。其相关个股中，Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为1078.21%、598.41%、564.65%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为64.05%、61.16%、60.87%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233627abdc8ea9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233627abdc8ea9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LEXXW","LEXX"],"gpt_icon":0},{"id":"2514999705","title":"Lexaria Bioscience Corp.盤中異動 快速上漲5.51%報1.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514999705","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514999705?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 04:53","pubTimestamp":1740430394,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日04时53分，Lexaria Bioscience Corp.股票出现异动，股价急速上涨5.51%。截至发稿，该股报1.53美元/股，成交量7.5923万股，换手率0.43%，振幅7.59%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体跌幅为0.36%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225045314abdb5d9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225045314abdb5d9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXXW","LEXX","BK4007"],"gpt_icon":0},{"id":"2512859814","title":"Lexaria Bioscience Corp.盤中異動 快速拉昇5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512859814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512859814?lang=zh_tw&edition=fundamental","pubTime":"2025-02-19 22:52","pubTimestamp":1739976766,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时52分，Lexaria Bioscience Corp.股票出现波动，股价急速上涨5.29%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Osr Holdings Inc C/Wts 02/09/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为333.70%、220.56%、71.44%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Allogene Therapeutics, Inc.，振幅分别为207.68%、98.28%、36.97%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192252479628d165&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192252479628d165&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXXW","LEXX","BK4007"],"gpt_icon":0},{"id":"2512199586","title":"Lexaria Bioscience Corp.盤中異動 快速下挫5.00%報1.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512199586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512199586?lang=zh_tw&edition=fundamental","pubTime":"2025-02-19 03:28","pubTimestamp":1739906905,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时28分，Lexaria Bioscience Corp.股票出现异动，股价快速下挫5.00%。截至发稿，该股报1.52美元/股，成交量4.5936万股，换手率0.26%，振幅8.12%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体涨幅为1.03%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190328269627c705&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190328269627c705&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXX","BK4007","LEXXW"],"gpt_icon":0},{"id":"2511694261","title":"Lexaria Bioscience Corp.盤中異動 股價大漲5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511694261","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511694261?lang=zh_tw&edition=fundamental","pubTime":"2025-02-14 23:23","pubTimestamp":1739546590,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时23分，Lexaria Bioscience Corp.股票出现波动，股价大幅拉升5.23%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Moleculin Biotech, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Cns Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2430.41%、627.61%、476.65%，振幅较大的相关个股有Moleculin Biotech, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为66.93%、54.40%、43.67%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021423231196232769&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021423231196232769&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXXW","LEXX","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":46,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LEXXW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LEXXW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LEXXW\",market:\"US\",delay:false,,,undefined,":{}}}